Like Sand In An Hourglass
Imagine an hourglass — but instead of sand, what flows are cysts. Thousands of small cysts, each the size of a pinhead, then the size of a peanut, then an olive, finally the size of an orange. They don't make noise. They don't press on nerves. They don't cause pain. They just grow — slowly, patiently, and completely invisible to the naked eye or even the body's own instincts. This is not a metaphor. This is the daily anatomy for those who carry the
PKD1 or
PKD2 gene mutation. Autosomal dominant polycystic kidney disease (ADPKD) is not a disease that attacks with turbulence; it is a disease that progresses like time — unnoticed, yet inevitable.
Genes That Convey Inheritance Without Permission
Every human inherits two copies of each gene: one from the mother, one from the father. In ADPKD, only one copy of the
PKD1 gene (on chromosome 16) or
PKD2 gene (on chromosome 4) needs to be faulty — and the inheritance is already set. What is the risk of a child inheriting this mutation from an affected parent? Not 25%, not 50% — but exactly 50%. It is not fate. It is an unchangeable law of genetics. What makes ADPKD so surprising is not only its prevalence — one in 1,000 people worldwide carries it — but also its variability: two siblings can have the same mutation, yet one may develop kidney failure at age 38, while the other still functions fully at age 72. Why? Because
modifier genes, adjustment genes that whisper in the background, accelerate or slow down cyst growth like wind changing the direction of sand in the desert.
The Body Becoming Cystic Islands
The kidneys are not the only battlefield. ADPKD is a systemic disease that pretends to be local. In the liver: liver cysts are found in more than 80% of adult patients — not just 'there,' but sometimes reaching 20 cm, pressing on the stomach and causing a false sense of fullness. In the pancreas: small cysts rarely cause problems, but they become important indicators in family screening. In the brain: intracranial aneurysms — 'fragile balloons' in the walls of arteries — lurk in 10% of cases, waiting for blood pressure to rise, stress to increase, or suddenly burst without warning. In the heart: mitral valve prolapse — a soft 'click' heard in a stethoscope often ignored, but can be the beginning of long-term heart dysfunction. Even in the arachnoid membrane — the protective layer of the brain — cysts can form, causing chronic headaches misdiagnosed as regular migraines.
When Kidneys Stop Beating in Silence
More than half of ADPKD patients eventually reach the end-stage kidney failure — not in a few months, but in decades. And here lies the hidden tragedy: loss of kidney function often occurs without clear symptoms until 60–70% of function has been lost. Rising blood pressure? It can be considered 'work stress.' Constant fatigue? 'Lack of sleep.' Foamy urine? 'Maybe not enough water.' The human body, in ADPKD, becomes a poor translator of its own condition. A study at the Universiti Sains Malaysia Hospital found that the average patient was diagnosed at age 44 — but the genetic mutation had been present since birth, and the first cysts could be detected via ultrasound in children as young as five years old. This means: two decades passed without detection. Two decades during which early intervention — strict blood pressure control, use of tolvaptan (a drug that slows cyst growth), and regular MRI monitoring — could have extended kidney function by an additional 10–15 years.
Not the End of the Story — But a Turning Point
ADPKD is not a death sentence. It is a diagnosis that requires an epic approach: a combination of genetics, advanced imaging, and family-centered medicine. At the Hereditary Kidney Disease Center at the National Heart Institute, patients now undergo a 'molecular risk profile' — a DNA test that not only confirms the mutation but also identifies
PKD1 variants associated with rapid progression. At the University of Malaya's systems biology laboratory, scientists are studying how specific microRNAs can 'turn off' cyst growth signals — not by killing cells, but by restoring the original tone of the gene.
And in a small house in Kota Bharu, a 59-year-old retired teacher — who started dialysis at age 51 — is now a facilitator of an ADPKD support group. He doesn't talk about 'disease.' He talks about 'time given back.' Every growing cyst is proof that his body is still fighting. Every erythropoietin injection is a reminder that life is not about perfection — but about sustaining dignity. ADPKD may not be curable today. But for the first time in medical history, we are no longer waiting for cysts to grow. We are learning to read their language — slowly, patiently, and with respect.
Rujukan: Autosomal dominant polycystic kidney disease — Wikipedia
He Lives With 2000 Cysts In His Kidneys — But Never Felt Pain Until Age 47. Inside the body of a normal man from Kelantan, more than two thousand cysts slowly grow — like small islands filled with fluid that expand silently. No fever. No back pain. No warning from his body… until one day, his kidneys stop beating in silence. This is not a fictional story — this is ADPKD: a hereditary disease that disguises itself as a normal condition for years.. Like Sand In An Hourglass
Imagine an hourglass — but instead of sand, what flows are cysts. Thousands of small cysts, each the size of a pinhead, then the size of a peanut, then an olive, finally the size of an orange. They don't make noise. They don't press on nerves. They don't cause pain. They just grow — slowly, patiently, and completely invisible to the naked eye or even the body's own instincts. This is not a metaphor. This is the daily anatomy for those who carry the PKD1 or PKD2 gene mutation. Autosomal dominant polycystic kidney disease ADPKD is not a disease that attacks with turbulence; it is a disease that progresses like time — unnoticed, yet inevitable.
Genes That Convey Inheritance Without Permission
Every human inherits two copies of each gene: one from the mother, one from the father. In ADPKD, only one copy of the PKD1 gene on chromosome 16 or PKD2 gene on chromosome 4 needs to be faulty — and the inheritance is already set. What is the risk of a child inheriting this mutation from an affected parent? Not 25%, not 50% — but exactly 50%. It is not fate. It is an unchangeable law of genetics. What makes ADPKD so surprising is not only its prevalence — one in 1,000 people worldwide carries it — but also its variability: two siblings can have the same mutation, yet one may develop kidney failure at age 38, while the other still functions fully at age 72. Why? Because modifier genes , adjustment genes that whisper in the background, accelerate or slow down cyst growth like wind changing the direction of sand in the desert.
The Body Becoming Cystic Islands
The kidneys are not the only battlefield. ADPKD is a systemic disease that pretends to be local. In the liver: liver cysts are found in more than 80% of adult patients — not just 'there,' but sometimes reaching 20 cm, pressing on the stomach and causing a false sense of fullness. In the pancreas: small cysts rarely cause problems, but they become important indicators in family screening. In the brain: intracranial aneurysms — 'fragile balloons' in the walls of arteries — lurk in 10% of cases, waiting for blood pressure to rise, stress to increase, or suddenly burst without warning. In the heart: mitral valve prolapse — a soft 'click' heard in a stethoscope often ignored, but can be the beginning of long-term heart dysfunction. Even in the arachnoid membrane — the protective layer of the brain — cysts can form, causing chronic headaches misdiagnosed as regular migraines.
When Kidneys Stop Beating in Silence
More than half of ADPKD patients eventually reach the end-stage kidney failure — not in a few months, but in decades. And here lies the hidden tragedy: loss of kidney function often occurs without clear symptoms until 60–70% of function has been lost. Rising blood pressure? It can be considered 'work stress.' Constant fatigue? 'Lack of sleep.' Foamy urine? 'Maybe not enough water.' The human body, in ADPKD, becomes a poor translator of its own condition. A study at the Universiti Sains Malaysia Hospital found that the average patient was diagnosed at age 44 — but the genetic mutation had been present since birth, and the first cysts could be detected via ultrasound in children as young as five years old. This means: two decades passed without detection. Two decades during which early intervention — strict blood pressure control, use of tolvaptan a drug that slows cyst growth , and regular MRI monitoring — could have extended kidney function by an additional 10–15 years.
Not the End of the Story — But a Turning Point
ADPKD is not a death sentence. It is a diagnosis that requires an epic approach: a combination of genetics, advanced imaging, and family-centered medicine. At the Hereditary Kidney Disease Center at the National Heart Institute, patients now undergo a 'molecular risk profile' — a DNA test that not only confirms the mutation but also identifies PKD1 variants associated with rapid progression. At the University of Malaya's systems biology laboratory, scientists are studying how specific microRNAs can 'turn off' cyst growth signals — not by killing cells, but by restoring the original tone of the gene.
And in a small house in Kota Bharu, a 59-year-old retired teacher — who started dialysis at age 51 — is now a facilitator of an ADPKD support group. He doesn't talk about 'disease.' He talks about 'time given back.' Every growing cyst is proof that his body is still fighting. Every erythropoietin injection is a reminder that life is not about perfection — but about sustaining dignity. ADPKD may not be curable today. But for the first time in medical history, we are no longer waiting for cysts to grow. We are learning to read their language — slowly, patiently, and with respect.
Rujukan: Autosomal dominant polycystic kidney disease — Wikipedia https://en.wikipedia.org/wiki/Autosomal dominant polycystic kidney disease
